Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,618,246 papers from all fields of science
Search
Sign In
Create Free Account
refractory hairy cell leukemia
Known as:
Hairy Cell Leukemia, Refractory
, leukemia, hairy cell, recurrent
, recurrent hairy cell leukemia
Expand
Hairy cell leukemia that is resistant to treatment.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
18 relations
Atypical lymphocyte
B lymphoblast
B-Lymphocytes
BRAF gene
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
R. Kreitman
,
C. Dearden
,
+40 authors
F. Giles
Leukemia
2018
Corpus ID: 49891272
This is a pivotal, multicenter, open-label study of moxetumomab pasudotox, a recombinant CD22-targeting immunotoxin, in hairy…
Expand
2017
2017
Ibrutinib for relapsed refractory hairy cell leukemia variant
Jan-Paul Bohn
,
D. Wanner
,
M. Steurer
Leukemia & lymphoma
2017
Corpus ID: 4621708
The variant form of hairy cell leukemia (vHCL) is a rare chronic B-cell malignancy classified separately from classic hairy cell…
Expand
Highly Cited
2013
Highly Cited
2013
Bendamustine and Rituximab in Relapsed and Refractory Hairy Cell Leukemia
M. Burotto
,
M. Stetler-Stevenson
,
E. Arons
,
Hong Zhou
,
W. Wilson
,
R. Kreitman
Clinical Cancer Research
2013
Corpus ID: 10130983
Purpose: To determine tolerability and for the first time explore efficacy of bendamustine–rituximab (BR) in multiply relapsed…
Expand
2013
2013
Successful vemurafenib salvage treatment in a patient with primary refractory hairy cell leukemia and pulmonary aspergillosis
H. Maurer
,
P. Haas
,
T. Wengenmayer
,
M. Lübbert
,
J. Duyster
,
R. Zeiser
Annals of Hematology
2013
Corpus ID: 36771951
Dear Editor, Hairy-cell leukemia (HCL) is a rare hematological malignancy, which typically responds very well to first-line…
Expand
Highly Cited
2013
Highly Cited
2013
Major Cancer Regressions in Mesothelioma After Treatment with an Anti-Mesothelin Immunotoxin and Immune Suppression
R. Hassan
,
Andrew C. Miller
,
+8 authors
I. Pastan
Science Translational Medicine
2013
Corpus ID: 206682849
In patients with advanced chemotherapy-refractory mesothelioma, treatment with the anti-mesothelin immunotoxin SS1P and…
Expand
2012
2012
Fludarabine and rituximab for relapsed or refractory hairy cell leukemia.
A. Gerrie
,
L. Zypchen
,
J. Connors
Blood
2012
Corpus ID: 206904699
The purine analogs, pentostatin and cladribine, induce high remission rates when used as first-line monotherapy for hairy cell…
Expand
2007
2007
The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia
M. Else
,
N. Osuji
,
+6 authors
D. Catovsky
Cancer
2007
Corpus ID: 28996278
The purine analogs pentostatin and cladribine have revolutionized the treatment of hairy cell leukemia (HCL) with overall…
Expand
Highly Cited
2003
Highly Cited
2003
Rituximab in relapsed or refractory hairy cell leukemia.
Deborah A. Thomas
,
S. O'brien
,
+5 authors
H. Kantarjian
Blood
2003
Corpus ID: 29565008
The purpose of this study was to investigate the efficacy and safety of the monoclonal antibody, rituximab, in relapsed or…
Expand
Highly Cited
1999
Highly Cited
1999
Responses in refractory hairy cell leukemia to a recombinant immunotoxin.
R. Kreitman
,
W. Wilson
,
+4 authors
I. Pastan
Blood
1999
Corpus ID: 2190722
We report major responses in 4 of 4 patients with hairy cell leukemia (HCL) who have recently been treated on a phase I trial…
Expand
1991
1991
Fludarabine phosphate in refractory hairy cell leukemia
E. Kraut
,
H. Chun
American journal of hematology
1991
Corpus ID: 38711922
Our experience suggests a potential role of fludarabine phosphate in the management of hairy cell leukemia. On the basis of this…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE